Literature DB >> 16691091

Manual therapy, physical therapy, or continued care by the general practitioner for patients with neck pain: long-term results from a pragmatic randomized clinical trial.

Jan L Hoving1, Henrica C W de Vet, Bart W Koes, Henk van Mameren, Walter L J M Devillé, Daniëlle A W M van der Windt, Willem J J Assendelft, Jan J M Pool, Rob J P M Scholten, Ingeborg B C Korthals-de Bos, Lex M Bouter.   

Abstract

OBJECTIVES: The authors' goals were to compare the effectiveness of manual therapy (MT; mainly spinal mobilization), physical therapy (PT; mainly exercise therapy), and continued care by the general practitioner (GP; analgesics, counseling and education) over a period of 1 year.
METHODS: One hundred eighty-three patients suffering for at least 2 weeks from nonspecific neck pain were randomized to receive a 6-week treatment strategy of MT once a week, PT twice a week, or GP care once every 2 weeks. The primary outcome measures were perceived recovery, severity of physical dysfunctioning, pain intensity, and functional disability.
RESULTS: The differences between groups considered over 1 year were statistically significant (repeated measurements analyses P<0.001 to P=0.02) for all outcomes but borderline for the Neck Disability Index (P=0.06). Higher improvement scores were observed for MT for all outcomes, followed by PT and GP care. The success rate, based on perceived recovery after 13 weeks, was 72% for MT, which was significantly higher than the success rate for continued GP care (42%, P=0.001) but not significantly higher compared with PT treatment (59%, P=0.16). The difference between PT and GP approached statistical significance (P=0.06). After 1 year the success rates were 75%, 63%, and 56%, respectively, and no longer significantly different.
CONCLUSIONS: Short-term results (at 7 weeks) have shown that MT speeded recovery compared with GP care and, to a lesser extent, also compared with PT. In the long-term, GP treatment and PT caught up with MT, and differences between the three treatment groups decreased and lost statistical significance at the 13-week and 52-week follow-up.

Entities:  

Mesh:

Year:  2006        PMID: 16691091     DOI: 10.1097/01.ajp.0000180185.79382.3f

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  31 in total

1.  A systematic review and meta-analysis of efficacy, cost-effectiveness, and safety of selected complementary and alternative medicine for neck and low-back pain.

Authors:  Andrea D Furlan; Fatemeh Yazdi; Alexander Tsertsvadze; Anita Gross; Maurits Van Tulder; Lina Santaguida; Joel Gagnier; Carlo Ammendolia; Trish Dryden; Steve Doucette; Becky Skidmore; Raymond Daniel; Thomas Ostermann; Sophia Tsouros
Journal:  Evid Based Complement Alternat Med       Date:  2011-11-24       Impact factor: 2.629

2.  Responsiveness and minimal important changes for the Neck Disability Index and the Neck Pain Disability Scale in Italian subjects with chronic neck pain.

Authors:  Marco Monticone; Emilia Ambrosini; Howard Vernon; Roberto Brunati; Barbara Rocca; Calogero Foti; Simona Ferrante
Journal:  Eur Spine J       Date:  2015-02-07       Impact factor: 3.134

3.  Multimodal management of mechanical neck pain using a treatment based classification system.

Authors:  Megan M Heintz; Eric J Hegedus
Journal:  J Man Manip Ther       Date:  2008

Review 4.  Management of neck pain and associated disorders: A clinical practice guideline from the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration.

Authors:  Pierre Côté; Jessica J Wong; Deborah Sutton; Heather M Shearer; Silvano Mior; Kristi Randhawa; Arthur Ameis; Linda J Carroll; Margareta Nordin; Hainan Yu; Gail M Lindsay; Danielle Southerst; Sharanya Varatharajan; Craig Jacobs; Maja Stupar; Anne Taylor-Vaisey; Gabrielle van der Velde; Douglas P Gross; Robert J Brison; Mike Paulden; Carlo Ammendolia; J David Cassidy; Patrick Loisel; Shawn Marshall; Richard N Bohay; John Stapleton; Michel Lacerte; Murray Krahn; Roger Salhany
Journal:  Eur Spine J       Date:  2016-03-16       Impact factor: 3.134

Review 5.  Neck pain.

Authors:  Allan I Binder
Journal:  BMJ Clin Evid       Date:  2008-08-04

6.  The long-term effects of naprapathic manual therapy on back and neck pain - results from a pragmatic randomized controlled trial.

Authors:  Eva Skillgate; Tony Bohman; Lena W Holm; Eva Vingård; Lars Alfredsson
Journal:  BMC Musculoskelet Disord       Date:  2010-02-05       Impact factor: 2.362

7.  [Randomized clinical trial for primary care patients with neck pain: manual therapy versus electrical stimulation].

Authors:  Esperanza Escortell Mayor; Gerardo Lebrijo Pérez; Yolanda Pérez Martín; Angel Asúnsolo del Barco; Rosario Riesgo Fuertes; Carmen Saa Requejo
Journal:  Aten Primaria       Date:  2008-07       Impact factor: 1.137

8.  Exploring patient satisfaction: a secondary analysis of a randomized clinical trial of spinal manipulation, home exercise, and medication for acute and subacute neck pain.

Authors:  Brent D Leininger; Roni Evans; Gert Bronfort
Journal:  J Manipulative Physiol Ther       Date:  2014-09-08       Impact factor: 1.437

9.  Protocol of a randomized controlled trial of the effectiveness of physician education and activation versus two rehabilitation programs for the treatment of Whiplash-associated Disorders: The University Health Network Whiplash Intervention Trial.

Authors:  Pierre Côté; J David Cassidy; Simon Carette; Eleanor Boyle; Heather M Shearer; Maja Stupar; Carlo Ammendolia; Gabrielle van der Velde; Jill A Hayden; Xiaoqing Yang; Maurits van Tulder; John W Frank
Journal:  Trials       Date:  2008-12-24       Impact factor: 2.279

10.  The effectiveness and cost-evaluation of manual therapy and physical therapy in patients with sub-acute and chronic non specific neck pain. Rationale and design of a Randomized Controlled Trial (RCT).

Authors:  Ruud Groeneweg; Hans Kropman; Huco Leopold; Luite van Assen; Jan Mulder; Maurits W van Tulder; Rob A B Oostendorp
Journal:  BMC Musculoskelet Disord       Date:  2010-01-24       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.